Literature DB >> 22240038

Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.

Silvia Franchi1, Sarah Moretti, Mara Castelli, Donatella Lattuada, Cinzia Scavullo, Alberto E Panerai, Paola Sacerdote.   

Abstract

Opioids have been shown to affect both innate and adaptive immunity. We previously showed that morphine affects the macrophage production of pro-inflammatory cytokines after LPS in a NFkB dependent manner. Toll like receptors (TLRs) play a crucial role in the signaling pathways which lead to NFkB activation. TLR4 is considered the Lipopolysaccaride (LPS) receptor. The data here presented show that, in murine macrophages, morphine impacts on the immune function acting on the early step of pathogen recognition. Morphine, when added to RAW 264.7 cells and when injected into mice (s.c. 20mg/kg) is in fact able to decrease TLR4 both at mRNA and protein level in RAW cells and peritoneal macrophages. In the same cells, the mu opioid receptor (MOR) antagonist Naltrexone increases TLR4 levels, thus suggesting a role of the endogenous opioid system in TLR4 regulation. The effect of the two drugs is moreover lost in case of co-administration. Experiments with MOR KO mice and with DAMGO (MOR specific agonist) confirm that the effect of morphine on TLR4 mRNA in peritoneal macrophages is due to the MOR activation. Moreover the effect on TLR4 is blocked by PTX thus indicating the involvement of a G(i) protein after MOR binding. This work unveils a clear link between MOR activation and TLR4, suggesting a new possible mechanism at the basis of the peripheral immunosuppressive effect of opioids. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240038     DOI: 10.1016/j.bbi.2011.12.010

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  30 in total

1.  Suppression of Human Natural Killer Cells by Different Classes of Opioids.

Authors:  Dermot P Maher; Deepa Walia; Nicola M Heller
Journal:  Anesth Analg       Date:  2019-05       Impact factor: 5.108

2.  Sex Differences in Microglia Activity within the Periaqueductal Gray of the Rat: A Potential Mechanism Driving the Dimorphic Effects of Morphine.

Authors:  Hillary H Doyle; Lori N Eidson; David M Sinkiewicz; Anne Z Murphy
Journal:  J Neurosci       Date:  2017-02-20       Impact factor: 6.167

3.  Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.

Authors:  Junliang Qian; Yanan Zhu; Liying Bai; Yan Gao; Mingjun Jiang; Fei Xing; Jian Zhang; Wenchao Zhao; Hanwen Gu; Yang Mi; Yuan-Xiang Tao; Ji-Tian Xu
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

4.  Quercetin inhibits gout arthritis in mice: induction of an opioid-dependent regulation of inflammasome.

Authors:  Kenji W Ruiz-Miyazawa; Larissa Staurengo-Ferrari; Sandra S Mizokami; Talita P Domiciano; Fabiana T M C Vicentini; Doumit Camilios-Neto; Wander R Pavanelli; Phileno Pinge-Filho; Flávio A Amaral; Mauro M Teixeira; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflammopharmacology       Date:  2017-05-15       Impact factor: 4.473

Review 5.  Sex differences in innate immunity and its impact on opioid pharmacology.

Authors:  Hillary H Doyle; Anne Z Murphy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 6.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

7.  Chronic morphine-induced microRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6.

Authors:  Shuwei Qiu; Yimin Feng; Gene LeSage; Ying Zhang; Charles Stuart; Lei He; Yi Li; Yi Caudle; Ying Peng; Deling Yin
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

8.  Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.

Authors:  H H Doyle; A Z Murphy
Journal:  Physiol Behav       Date:  2017-12-01

9.  Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.

Authors:  Alexander T Podolsky; Alexander Sandweiss; Jackie Hu; Edward J Bilsky; Jim P Cain; Vlad K Kumirov; Yeon Sun Lee; Victor J Hruby; Ruben S Vardanyan; Todd W Vanderah
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

10.  Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.

Authors:  C W Stevens; S Aravind; S Das; R L Davis
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.